Lynne H Brum's Net Worth
$22.1 Million
Who is Lynne H Brum?
Lynne H Brum has an estimated net worth of $22.1 Million. This is based on reported shares across multiple companies, which include Altus Pharmaceuticals Inc., YIELD10 BIOSCIENCE, INC., and VERTEX PHARMACEUTICALS INC / MA.
SEC CIK
Lynne H Brum's CIK is 0001197017
Past Insider Trading and Trends
2006 was Lynne H Brum's most active year for acquiring shares with 21 total transactions. Lynne H Brum's most active month to acquire stocks was the month of January. 2006 was Lynne H Brum's most active year for disposing of shares, totalling 40 transactions. Lynne H Brum's most active month to dispose stocks was the month of February. 2015 saw Lynne H Brum paying a total of $50,011.53 for 572,088 shares, this is the most they've acquired in one year. In 2006 Lynne H Brum cashed out on 41,388 shares for a total of $805,504.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Altus Pharmaceuticals Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +87.49% | 381.6K |
—
|
—
| 817.75K |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
YIELD10 BIOSCIENCE, INC. (YTEN) Snapshot price: $1.08
VP Planning and Communications
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.08% | -731.00 |
$1.50 | -$1,096.50 | 5.87K |
Aug 15
| |||
Form 4
| +1,201.06% | 100K |
$0.30 | $30,000.00 | 108.33K |
Feb 15
| |||
Form 4
| -11.00% | -1.03K |
$3.59 | -$3,694.11 | 8.32K |
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
| -8.46% | -864.00 |
$2.68 | -$2,315.52 | 9.35K |
Aug 10
| |||
Form 4
| -3.46% | -366.00 |
$4.25 | -$1,555.50 | 10.22K |
Mar 1
| |||
Form 4
| +125.58% | 5.89K |
$3.83 | $22,562.53 | 10.58K |
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
| -6.14% | -307.00 |
$6.71 | -$2,059.97 | 4.69K |
Sep 1
| |||
Form 4
| +71.99% | 2.09K |
$16.03 | $33,534.76 | 5K |
Mar 1
| |||
Form 4
| -19.26% | -693.00 |
$22.77 | -$15,779.61 | 2.91K |
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| -14.02% | -587.00 |
$6.55 | -$3,844.85 | 3.6K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
| +2,150.54% | 4K |
—
|
—
| 4.19K |
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| -8.33% | -679.00 |
$1.16 | -$787.64 | 7.47K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
| -7.63% | -7.39K |
$0.37 | -$2,735.04 | 89.47K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 4
| -9.45% | -10.10K |
$1.86 | -$18,793.44 | 96.87K |
Apr 1
| |||
Form 4
| +874.55% | 14.57K |
$3.32 | $48,372.40 | 16.24K |
Jun 18 - Jun 19
| |||
Form 4
| +5,444.05% | 544.4K |
—
|
—
| 554.4K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
∞
| 10K |
$1.07 | $10,700.00 | 10K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468
VP, Strategic Communications
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$25.54 | -$49,635.00 | 46.2K |
Scheduled
|
May 8
| ||
Form 4
|
—
|
0
|
$25.14 | -$47,835.00 | 46.2K |
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$26.95 | -$22,770.00 | 46.2K |
Scheduled
|
Apr 24
| ||
Form 4
|
—
|
0
|
$25.68 | -$20,230.00 | 46.2K |
Scheduled
|
Apr 17
| ||
Form 4
|
—
|
0
|
$24.74 | -$18,360.00 | 46.2K |
Scheduled
|
Apr 10
| ||
Form 4
|
—
|
0
|
$25.77 | -$20,420.00 | 46.2K |
Scheduled
|
Apr 3
| ||
Form 4
|
—
|
0
|
$25.72 | -$20,310.00 | 46.2K |
Scheduled
|
Mar 20 - Mar 27
| ||
Form 4
| -4.13% | -1.99K |
$36.56 | -$72,681.28 | 46.2K |
Scheduled
|
Mar 24
| ||
Form 4
| -0.82% | -400.00 |
$27.84 | -$40,608.00 | 48.19K |
Scheduled
|
Mar 20
| ||
Form 4
|
—
|
0
|
$26.40 | -$21,670.00 | 48.59K |
Scheduled
|
Mar 13
| ||
Form 4
|
—
|
0
|
$29.75 | -$28,380.00 | 48.59K |
Scheduled
|
Mar 6
| ||
Form 4
|
—
|
0
|
$29.72 | -$28,310.00 | 48.59K |
Scheduled
|
Feb 27
| ||
Form 4
|
—
|
0
|
$26.35 | -$21,570.00 | 48.59K |
Scheduled
|
Feb 21
| ||
Form 4
|
—
|
0
|
$25.26 | -$19,400.00 | 48.59K |
Scheduled
|
Feb 13
| ||
Form 4
|
—
|
0
|
$24.95 | -$18,770.00 | 48.59K |
Scheduled
|
Feb 6
| ||
Form 4
| +7.14% | 3.24K |
$0.01 | $32.40 | 48.59K |
Feb 2
| |||
Form 4
|
—
|
0
|
$25.43 | -$19,730.00 | 44.2K |
Scheduled
|
Jan 31
| ||
Form 4
|
—
|
0
|
$24.60 | -$18,070.00 | 44.2K |
Scheduled
|
Jan 23
| ||
Form 4
|
—
|
0
|
$24.59 | -$18,060.00 | 44.2K |
Scheduled
|
Jan 17
| ||
Form 4
|
—
|
0
|
$17.15 | -$30,600.00 | 44.2K |
Scheduled
|
Dec 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
| +5.68% | 2.38K |
$0.01 | $23.75 | 44.2K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 7
| |||
Form 4
| +513.12% | 35K |
$0.01 | $350.00 | 41.82K |
May 6
| |||
Form 4
| +13.29% | 800 |
$0.01 | $8.00 | 6.82K |
Mar 17
| |||
Form 4
| +15.32% | 800 |
—
|
—
| 6.02K |
Dec 11
| |||
| No matching records found | |||||||||